Literature DB >> 19285686

Erythropoietin attenuates lung injury in lipopolysaccharide treated rats.

You Shang1, Xingwang Li, Pramod V Prasad, Sanpeng Xu, Shanglong Yao, Dong Liu, Shiying Yuan, Dan Feng.   

Abstract

BACKGROUND: Erythropoietin (EPO) elicits protective effects in lung ischemia-reperfusion, hyperoxia, acute necrotizing pancreatitis, and some other tissues. In the present study, we investigated the possible protective roles of EPO in the lipopolysaccharide (LPS) induced lung injury.
MATERIALS AND METHODS: Male Sprague-Dawley rats were treated with EPO (3000 U/kg, i.p.) or vehicle (saline), 30 min prior to LPS administration (6 mg/kg, i.v.). Four h following LPS injection, samples of pulmonary tissue were collected. Optical microscopy was performed to examine pathological changes in lungs. Validated methods were used to measure wet/dry ratios (W/D), myeloperoxidase (MPO) activity, malondialdehyde (MDA) concentrations, and nitrite/nitrate (NO(2)(-)/NO(3)(-)) levels in lungs. Western blotting was performed to study the pulmonary expression of inducible nitric oxide synthase (iNOS) and nitrotyrosine protein.
RESULTS: Pretreatment with EPO led to (1) significant attenuation of endotoxemia induced evident lung histologic injury and edema; (2) inhibition of LPS mediated induction in MPO activity and MDA concentration; (3) inhibition of LPS mediated overproduction of pulmonary NO(2)(-)/NO(3)(-) levels; and (4) marked suppression in endotoxin induced expression of iNOS and nitrotyrosine.
CONCLUSIONS: This study provides considerable evidence that EPO has an ability to significantly attenuate endotoxin-induced acute lung injury in rats.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19285686     DOI: 10.1016/j.jss.2008.10.003

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  13 in total

1.  Neuroprotective effect of lipoxin A4 methyl ester in a rat model of permanent focal cerebral ischemia.

Authors:  Yan Wu; Xi-Hong Ye; Pei-Pei Guo; San-Peng Xu; Jie Wang; Shi-Ying Yuan; Shang-Long Yao; You Shang
Journal:  J Mol Neurosci       Date:  2010-04-17       Impact factor: 3.444

Review 2.  Erythropoetin as a novel agent with pleiotropic effects against acute lung injury.

Authors:  Sotirios Kakavas; Theano Demestiha; Panagiotis Vasileiou; Theodoros Xanthos
Journal:  Eur J Clin Pharmacol       Date:  2010-11-11       Impact factor: 2.953

3.  Mechanisms of nitric oxide synthase uncoupling in endotoxin-induced acute lung injury: role of asymmetric dimethylarginine.

Authors:  Shruti Sharma; Anita Smith; Sanjiv Kumar; Saurabh Aggarwal; Imran Rehmani; Connie Snead; Cynthia Harmon; Jeffery Fineman; David Fulton; John D Catravas; Stephen M Black
Journal:  Vascul Pharmacol       Date:  2009-12-03       Impact factor: 5.773

4.  Prophylactic erythropoietin exacerbates ventilation-induced lung inflammation and injury in preterm lambs.

Authors:  Graeme R Polglase; Samantha K Barton; Jacqueline M Melville; Valerie Zahra; Megan J Wallace; Melissa L Siew; Mary Tolcos; Timothy J M Moss
Journal:  J Physiol       Date:  2014-03-03       Impact factor: 5.182

5.  Luteolin Suppresses Inflammatory Mediator Expression by Blocking the Akt/NFκB Pathway in Acute Lung Injury Induced by Lipopolysaccharide in Mice.

Authors:  Yi-Ching Li; Chung-Hsin Yeh; Ming-Ling Yang; Yu-Hsiang Kuan
Journal:  Evid Based Complement Alternat Med       Date:  2011-11-20       Impact factor: 2.629

Review 6.  Neuroplasticity and the next wave of antidepressant strategies.

Authors:  Shawn Hayley; Darcy Litteljohn
Journal:  Front Cell Neurosci       Date:  2013-11-20       Impact factor: 5.505

7.  The effect of erythropoietin to pulmonary injury and mast cells secondary to acute pancreatitis.

Authors:  Tanzer Korkmaz; Nurettin Kahramansoy; Ali Kilicgun; Tulin Firat
Journal:  BMC Res Notes       Date:  2014-04-24

8.  EPO enhances the protective effects of MSCs in experimental hyperoxia-induced neonatal mice by promoting angiogenesis.

Authors:  Chao Sun; Shanshan Zhang; Jue Wang; Wen Jiang; Qian Xin; Xiaojing Chen; Zhaohua Zhang; Yun Luan
Journal:  Aging (Albany NY)       Date:  2019-04-29       Impact factor: 5.682

Review 9.  Erythropoietin as candidate for supportive treatment of severe COVID-19.

Authors:  Hannelore Ehrenreich; Karin Weissenborn; Martin Begemann; Markus Busch; Eduard Vieta; Kamilla W Miskowiak
Journal:  Mol Med       Date:  2020-06-16       Impact factor: 6.354

Review 10.  A Perspective on Erythropoietin as a Potential Adjuvant Therapy for Acute Lung Injury/Acute Respiratory Distress Syndrome in Patients with COVID-19.

Authors:  Adeleh Sahebnasagh; Mojataba Mojtahedzadeh; Farhad Najmeddin; Atabak Najafi; Mohammadreza Safdari; Hassan Rezai Ghaleno; Solomon Habtemariam; Ioana Berindan-Neagoe; Seyed Mohammad Nabavi
Journal:  Arch Med Res       Date:  2020-08-11       Impact factor: 2.235

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.